Clinical Trials Logo

Irritable Bowel Syndrome clinical trials

View clinical trials related to Irritable Bowel Syndrome.

Filter by:

NCT ID: NCT05941650 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome

To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome

Start date: December 2, 2024
Phase: N/A
Study type: Interventional

To evaluate whether there is clinical improvement through the scales (Bristol, IBS severity score, and IBS quality of life) in women with irritable bowel syndrome after administration of SC-FOS (short-chain fructooligosaccharides).

NCT ID: NCT05931107 Completed - Depression Clinical Trials

Effect of Stress Ball on Irritable Bowel Syndrome

Start date: July 19, 2023
Phase: N/A
Study type: Interventional

Objective: This study will be conducted to evaluate the effect of stress ball on symptom severity, quality of life, depression, anxiety and stress in patients with irritable bowel syndrome (IBS). Material and Method: The data of the randomized controlled experimental study will be collected at the gastroenterology outpatient clinic of Erzurum City Hospital. A simple randomization list was created with the Random Allocation Software program and it will be carried out with a total of 56 patients diagnosed with IBS, including 28 experimental and 28 control groups. Patients in the experimental group were asked to squeeze the stress ball for at least 10 minutes every day for 4 weeks. No treatment will be applied to those in the control group. Patient information form, IBS symptom severity score, IBS quality of life scale, Depression-Anxiety-Stress scale will be used to collect research data. Keywords: Irritable Bowel Syndrome, patient, stress ball, Depression, Anxiety, Stress, Quality of Life

NCT ID: NCT05923892 Recruiting - Clinical trials for Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type

Start date: August 2, 2023
Phase: Phase 2
Study type: Interventional

This is a A Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Trial to Evaluate the Efficacy and Safety of Different Doses of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea type (IBS-D).The trial is mainly divided into three periods: screening period, treatment period and follow-up period.

NCT ID: NCT05921383 Not yet recruiting - Clinical trials for Constipation-predominant Irritable Bowel Syndrome

Anorectal Manometry of Patients With Constipation Predominant IBS

Start date: July 1, 2023
Phase:
Study type: Observational

The aim of The study is to compare between the anorectal manometric profile of patients with functional constipation and patients with constipation predominant irritabe bowel syndrome

NCT ID: NCT05911347 Recruiting - Clinical trials for Irritable Bowel Syndrome

Effect of Modified Cellulose on Colonic Fermentation of Inulin

COCOA2
Start date: May 9, 2023
Phase: N/A
Study type: Interventional

A 3-way randomised cross-over study to test the hypothesis that combining either psyllium or methylcellulose to form a gel incorporating inulin will reduce gas production as compared to inulin given with a placebo, maltodextrin. Subjects will attend on 3 separate days separated by a minimum of one week an consume one of 3 test meals. Serial breath samples with be obtained to measure hydrogen and methane over the next 24 hours. Primary endpoint: Area under curve (AUC) from time 0-6 hours (AUC 0-6) of breath hydrogen (ppm.hour) after treatment intake. We will also assess whole gut transit time using the blue muffin and correlate breath hydrogen production with in vitro fermentation results.

NCT ID: NCT05905926 Enrolling by invitation - Clinical trials for Irritable Bowel Syndrome With Constipation (IBS-C)

Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

Start date: February 17, 2023
Phase: Phase 3
Study type: Interventional

Open-label long-term safety study of tenapanor in pediatric patients with IBS-C.

NCT ID: NCT05900752 Completed - Diarrhea Clinical Trials

A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients

Start date: June 19, 2023
Phase: N/A
Study type: Interventional

The goal of this interventional clinical study is to study whether the consumption of QiMeiYan Probiotics in 25-35 young people with Mild irritable bowel syndrome (IBS Score 75 - 175) will reduce the frequency of Diarrhea. 140 eligible participants (70 males and 70 females) will be enrolled in two study sites and randomly assigned to two groups of products QiMeiYan Probiotics and placebo. All participants will consume assigned products once a day after meals and record the critical data such as photo of feces. Three site visits will be arranged and all clinical data will be captured and recorded into CTMS (Clinical Trial Management System) for statistical analysis. Researchers will compare the two groups to validate if the daily consumption of QiMeiYan Probiotics will reduce the frequency of Diarrhea in the study population.

NCT ID: NCT05879692 Recruiting - Obesity Clinical Trials

Response of Irritable Bowel Syndrome to Abdominal Fat Reduction

Start date: May 28, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to find out the response of Irritable Bowel Syndrome (IBS) to abdominal fat reduction in central obese patients using: application of High Intensity Focused Ultrasound (cavitation) on the abdominal region, aerobic exercise and a dietary regimen that will be low in calories (Low Caloric Diet) and low in fermentable oligo-, di-, mono- saccharides and polyols (low-FODMAPs).

NCT ID: NCT05874830 Recruiting - Clinical trials for IBS - Irritable Bowel Syndrome

The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Start date: October 15, 2021
Phase: N/A
Study type: Interventional

The object of this study is to find out is there an optimal route for the fecal microbiata transplant (FMT) in patients that suffer from irritable bowel syndrome. The investigators compare outcomes in patients with repeated fecal microbiome samples and make symptomatic questionnaires (i.e. IBS-SSS, GSRS) to find out if there is difference in severity of symptoms compared to FMT given in duodenogastroscopy or in coloscopy.

NCT ID: NCT05867693 Recruiting - Clinical trials for Irritable Bowel Syndrome

Palmitoylethanolamide and Polydatin in Pediatric Irritable Bowel Syndrome

Start date: April 19, 2023
Phase: N/A
Study type: Interventional

This will be a randomised, double-blind, placebo-controlled, parallel-arm trial, designed to study the efficacy and safety of co-micronised palmithoylethanolamide/polydatin in pediatric patients (> 10 years) with Irritable bowel syndrome (IBS)